|
FY2021
12 months to Dec 31, 2021
|
FY2020
2 months to Dec 31, 2020
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Warrant issuance costs | ||
| Decrease in fair value of warrants | ||
| Interest earned on cash and marketable securities held in Trust Account | ||
| Prepaid expenses | ||
| Accrued professional fees | ||
| Accrued offering costs and expenses | ||
| Due to related party | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment held in Trust Account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from initial public offering, net of underwriters’ fees | ||
| Proceeds from private placement warrants | ||
| Repayment to promissory note to related party | ||
| Payments of offering costs | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock | ||
| Cash, end of the period | ||
| Supplemental disclosures of noncash investing and financing activities: | ||
| Deferred underwriting commissions charged to additional paid in capital | ||
| Offering costs paid by Sponsor in exchange for issuance of Class B common stock | ||
| Offering costs paid by Sponsor loan | ||
| Initial fair value of warrant liability |
Loading...
